Difference Expressions CD34 in Acute Myeloid Leukemia Cell Culture in the Administration of Cytarabine-Daunorubicine Dose Standards

• Main Authors: Muhammad Saiful Rahman, Paulus Budiono Notopuro, Suprapto Ma'at, Made Putra Sedana
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Association of Clinical Pathologists. 2021
• Subjects: RB Pathology
• Online Access: https://repository.unair.ac.id/127506/1/jurnal%20Difference%20Expressions%20CD34%20in%20Acute%20Myeloid%20Leukemia%20Cell%20Culture.pdf; https://repository.unair.ac.id/127506/2/karil%20Difference%20Expressions%20CD34%20in%20Acute%20Myeloid%20Leukemia%20Cell%20Culture%20in%20the%20Administration%20of%20Cytarabine-Daunorubicine%20Dose%20Standards.pdf; https://repository.unair.ac.id/127506/3/Difference%20Expressions%20CD34%2Bin%20Acute%20Myeloid%20Leukemia%20Cell%20Culture%20in%20the%20Administration%20of%20Cytarabine-Daunorubicine%20Dose%20Standards.pdf; https://repository.unair.ac.id/127506/
• Institution: Universitas Airlangga

The cure rate for patients with Acute Myeloid Leukemia (AML) is 20-75%. Standard-dose cytarabine + (SDAC)-daunorubicine gives a remission rate of ± 60%, and the case of relapse is frequently found. In-vivo CD34 expression is a reliable and straightforward test that must evaluate AML patients'...